SEC Form 13F
| Report period | 2024-09-30 |
|---|---|
| Publicly available | 2024-11-15 |
| Reported value | $43,659,366 |
| Positions | 3 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| KYVERNA THERAPEUTICS INC | KYTX | COM | $15,919,033 | 3,255,426 |
| VIGIL NEUROSCIENCE INC | VIGL | COM | $14,329,293 | 4,214,498 |
| CANDEL THERAPEUTICS INC | CADL | COM | $13,411,040 | 1,935,215 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.